Clinical trials for PDRN's multiple effects, including improved skin hydration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011479

Enrollment

Registered

2026-01-16

Start date

2025-10-22

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Consume 1 hard capsule (300 mg) of either the test product (containing Polydeoxyribonucleotide 200mg) product once daily.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Women aged 35 to 65 years 2) Those who have received a thorough explanation of the purpose and content of the test and voluntarily signed consent 3) Those who are available for follow-up observation during the test period 4) Healthy individuals without acute or chronic physical illnesses, including skin diseases

Exclusion criteria

Exclusion criteria: 1)Pregnant or lactating women, or women of childbearing potential who do not agree to use the contraceptive methods specified in the protocol. ? Women of childbearing potential must confirm non-pregnancy by a urine pregnancy test (hCG test) prior to participation and agree to use an appropriate contraceptive method throughout the study period. 2)Presence of a lesion at the test site. 3)Presence of an infectious skin disease. 4)History of allergy or hypersensitivity. 5)History of irritation or adverse reactions to cosmetics, medications, or routine light exposure. 6)Use of systemic steroids or receipt of phototherapy within one month prior to participation in the study. 7)Receipt of skin procedures (e.g., scaling, botulinum toxin injection, filler injection, laser treatment, or tattooing) within three months prior to participation in the study. 8)Participation in another human application study involving the same test area within one month prior to participation in this study. 9)Presence of psychiatric disorders, intellectual disability, or other mental conditions. 10)Known sensitivity or allergy to any ingredient of the test food. 11)Any other condition that, in the opinion of the principal investigator or study manager, makes participation in the study inappropriate or difficult.

Design outcomes

Primary

Measure	Time frame
Skin moisture;Skin wrinkling	—

Secondary

Measure	Time frame
Skin texture;Skin lifting ;Skin pore;Skin glowness ;Improvement of the test subjects	—

Countries

Korea, Republic of

Contacts

Public ContactInah Kim

Global Medical Research Center

inah@gmrc.co.kr+82-70-4139-0796

Outcome results